These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Synthesis and Structure-Activity Relationships of LP1 Derivatives: N-Methyl-N-phenylethylamino Analogues as Novel MOR Agonists. Turnaturi R; Parenti C; Prezzavento O; Marrazzo A; Pallaki P; Georgoussi Z; Amata E; Pasquinucci L Molecules; 2018 Mar; 23(3):. PubMed ID: 29547588 [TBL] [Abstract][Full Text] [Related]
11. LP1 and LP2: Dual-Target MOPr/DOPr Ligands as Drug Candidates for Persistent Pain Relief. Pasquinucci L; Parenti C; Georgoussi Z; Reina L; Tomarchio E; Turnaturi R Molecules; 2021 Jul; 26(14):. PubMed ID: 34299443 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological studies with a nonpeptidic, delta-opioid (-)-(1R,5R,9R)-5,9-dimethyl-2'-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((-)-NIH 11082). Aceto MD; May EL; Harris LS; Bowman ER; Cook CD Eur J Pharmacol; 2007 Jul; 566(1-3):88-93. PubMed ID: 17434480 [TBL] [Abstract][Full Text] [Related]
13. Electrophilic gamma-lactone kappa-opioid receptor probes. Analogues of 2'-hydroxy-2-tetrahydrofurfuryl-5,9-dimethyl-6,7-benzomorphan diastereomers. Klein P; Nelson WL J Med Chem; 1991 Aug; 34(8):2438-44. PubMed ID: 1652019 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as antagonists of the NMDA receptor-channel complex. Grauert M; Bechtel WD; Ensinger HA; Merz H; Carter AJ J Med Chem; 1997 Aug; 40(18):2922-30. PubMed ID: 9288174 [TBL] [Abstract][Full Text] [Related]
15. An LP1 analogue, selective MOR agonist with a peculiar pharmacological profile, used to scrutiny the ligand binding domain. Ronsisvalle S; Aricò G; Panarello F; Spadaro A; Pasquinucci L; Pappalardo MS; Parenti C; Ronsisvalle N Bioorg Med Chem; 2016 Nov; 24(21):5280-5290. PubMed ID: 27624520 [TBL] [Abstract][Full Text] [Related]
16. The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans. Metcalf MD; Aceto MD; Harris LS; Woods JH; Traynor JR; Coop A; May EL Bioorg Med Chem; 2008 Jan; 16(2):869-73. PubMed ID: 17962026 [TBL] [Abstract][Full Text] [Related]
18. In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the rat. Richards ML; Sadée W J Pharmacol Exp Ther; 1985 May; 233(2):425-32. PubMed ID: 2987482 [TBL] [Abstract][Full Text] [Related]
19. Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group. Traynor JR; Guo L; Coop A; Lewis JW; Woods JH J Pharmacol Exp Ther; 1999 Dec; 291(3):1093-9. PubMed ID: 10565829 [TBL] [Abstract][Full Text] [Related]
20. The Pharmacological Heterogeneity of Nepenthone Analogs in Conferring Highly Selective and Potent κ-Opioid Agonistic Activities. Li W; Long JD; Qian YY; Long Y; Xu XJ; Wang YJ; Shen Q; Wang ZN; Yang XC; Xiao L; Sun HP; Xu YL; Chen YY; Xie Q; Wang YH; Shao LM; Liu JG; Qiu ZB; Fu W ACS Chem Neurosci; 2017 Apr; 8(4):766-776. PubMed ID: 28033462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]